Identification of cross-reactive norovirus CD4+ T cell epitopes

Journal of Virology

Volumn 84, Issue 17, 2010, Pages 8530-8538

  LoBue, Anna D ^a   Lindesmith, Lisa C ^b   Baric, Ralph S ^a,b  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; GAMMA INTERFERON;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CROSS REACTION; CYTOKINE RELEASE; ENZYME IMMUNOASSAY; GENE CLUSTER; GENOTYPE; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; MOUSE; NONHUMAN; NOROVIRUS; PRIORITY JOURNAL; REPLICON; SPLEEN CELL; VENEZUELAN EQUINE ENCEPHALOMYELITIS ALPHAVIRUS; VIRUS INFECTION; VIRUS LIKE AGENT; VIRUS STRAIN; ANIMAL; BAGG ALBINO MOUSE; CALICIVIRUS INFECTION; CELL CULTURE; CHEMISTRY; CYTOLOGY; GENETICS; IMMUNOLOGY; MOLECULAR EVOLUTION; MOLECULAR GENETICS; SEQUENCE ALIGNMENT; SPECIES DIFFERENCE; SPLEEN; VIROLOGY;

ALPHAVIRUS; MIRIDAE; MUS; NOROVIRUS; NORWALK VIRUS; VENEZUELAN EQUINE ENCEPHALITIS VIRUS;

AMINO ACID SEQUENCE; ANIMALS; CALICIVIRIDAE INFECTIONS; CAPSID PROTEINS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; CROSS REACTIONS; EPITOPES, T-LYMPHOCYTE; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY, CELLULAR; INTERFERON-GAMMA; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; NOROVIRUS; SEQUENCE ALIGNMENT; SPECIES SPECIFICITY; SPLEEN;

EID: 77956639726     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00727-10     Document Type: Article

References (30)

1. Baric, R. S., et al. 2002. Expression and self-assembly of Norwalk virus capsid protein from Venezuelan equine encephalitis virus replicons. J. Virol. 76: 3023-3030.
2. Bernstein, D. I., et al. 2009. Randomized, double-blind, phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers. Vaccine 28:484-493.
3. Bertolotti-Ciarlet, A., et al. 2002. Structural requirements for the assembly of Norwalk virus-like particles. J. Virol. 76:4044-4055.
4. Cannon, J. L., et al. 2009. Herd immunity to GII.4 noroviruses is supported by outbreak patient sera. J. Virol. 83:5363-5374.
5. Chachu, K. A., et al. 2008. Immune mechanisms responsible for vaccination against and clearance of mucosal and lymphatic norovirus infection. PLoS Pathog. 4:e1000236.
6. Chachu, K. A., et al. 2008. Antibody is critical for the clearance of murine norovirus infection. J. Virol. 82:6610-6617.
7. Davis, N. L., et al. 2002. Alphavirus replicon particles as candidate HIV vaccines. IUBMB Life 53:209-211.
8. Erdman, D. D., G. W. Gary, and L. J. Anderson. 1989. Serum immunoglobulin A response to Norwalk virus infection. J. Clin. Microbiol. 27:1417-1418.
9. Farkas, T., et al. 2003. Homologous versus heterologous immune responses to Norwalk-like viruses among crew members after acute gastroenteritis outbreaks on 2 US Navy vessels. J. Infect. Dis. 187:187-193.
10. Gray, S. F., and M. R. Evans. 1993. Dose-response in an outbreak of non-bacterial food poisoning traced to a mixed seafood cocktail. Epidemiol. Infect. 110:583-590.
11. Green, K. Y., et al. 2002. A predominant role for Norwalk-like viruses as agents of epidemic gastroenteritis in Maryland nursing homes for the elderly. J. Infect. Dis. 185:133-146.
12. Hale, A. D., et al. 1998. Homotypic and heterotypic IgG and IgM antibody responses in adults infected with small round structured viruses. J. Med. Virol. 54:305-312.
13. Hale, A. D., et al. 2000. Identification of an epitope common to genogroup 1 "Norwalk-like viruses." J. Clin. Microbiol. 38:1656-1660.
14. Harrington, P. R., et al. 2002. Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice. J. Virol. 76:12335-12343.
15. Harrington, P. R., et al. 2002. Systemic, mucosal, and heterotypic immune induction in mice inoculated with Venezuelan equine encephalitis replicons expressing Norwalk virus-like particles. J. Virol. 76:730-742.
16. Johnson, P. C., et al. 1990. Multiple-challenge study of host susceptibility to Norwalk gastroenteritis in US adults. J. Infect. Dis. 161:18-21.
17. Lindesmith, L., et al. 2005. Cellular and humoral immunity following Snow Mountain virus challenge. J. Virol. 79:2900-2909.
18. Lindesmith, L. C., et al. 2010. Heterotypic humoral and cellular immune responses following Norwalk virus infection. J. Virol. 84:1800-1815.
19. Lindesmith, L. C., et al. 2008. Mechanisms of GII.4 norovirus persistence in human populations. PLoS Med. 5:e31.
20. LoBue, A. D., et al. 2006. Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains. Vaccine 24:5220-5234.
21. LoBue, A. D., et al. 2009. Alphavirus-adjuvanted norovirus-like particle vaccines: heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge. J. Virol. 83:3212-3227.
22. Nicollier-Jamot, B., et al. 2003. Molecular cloning, expression, self-assembly, antigenicity, and seroepidemiology of a genogroup II norovirus isolated in France. J. Clin. Microbiol. 41:3901-3904.
23. Noel, J. S., et al. 1997. Correlation of patient immune responses with genetically characterized small round-structured viruses involved in outbreaks of nonbacterial acute gastroenteritis in the United States, 1990 to 1995. J. Med. Virol. 53:372-383.
24. Parker, T. D., et al. 2005. Identification of genogroup I and genogroup II broadly reactive epitopes on the norovirus capsid. J. Virol. 79:7402-7409.
25. Parrino, T. A., et al. 1977. Clinical immunity in acute gastroenteritis caused by Norwalk agent. N. Engl. J. Med. 297:86-89.
26. Periwal, S. B., et al. 2003. A modified cholera holotoxin CT-E29H enhances systemic and mucosal immune responses to recombinant Norwalk virus-virus like particle vaccine. Vaccine 21:376-385.
27. Tacket, C. O., et al. 2003. Humoral, mucosal, and cellular immune responses to oral Norwalk virus-like particles in volunteers. Clin. Immunol. 108:241-247.
28. Thompson, J. M., et al. 2006. Mucosal and systemic adjuvant activity of alphavirus replicon particles. Proc. Natl. Acad. Sci. U. S. A. 103:3722-3727.
29. Treanor, J. J., et al. 1993. Subclass-specific serum antibody responses to recombinant Norwalk virus capsid antigen (rNV) in adults infected with Norwalk, Snow Mountain, or Hawaii virus. J. Clin. Microbiol. 31:1630-1634.
30. Wyatt, R. G., et al. 1974. Comparison of three agents of acute infectious nonbacterial gastroenteritis by cross-challenge in volunteers. J. Infect. Dis. 129:709-714.